These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 7849595)

  • 1. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
    Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
    Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of cholinesterases by huperzine A.
    Ashani Y; Peggins JO; Doctor BP
    Biochem Biophys Res Commun; 1992 Apr; 184(2):719-26. PubMed ID: 1575745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
    Ashani Y; Grunwald J; Kronman C; Velan B; Shafferman A
    Mol Pharmacol; 1994 Mar; 45(3):555-60. PubMed ID: 8145739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
    Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
    J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
    Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
    J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
    Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
    Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
    Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cholinesterase inhibition by inorganic mercury.
    Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D
    FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics of mouse acetylcholinesterase complexed with huperzine A.
    Tara S; Helms V; Straatsma TP; McCammon JA
    Biopolymers; 1999 Oct; 50(4):347-59. PubMed ID: 10423544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.
    Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Dec; 42(25):5110-9. PubMed ID: 10602696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement.
    Dvir H; Jiang HL; Wong DM; Harel M; Chetrit M; He XC; Jin GY; Yu GL; Tang XC; Silman I; Bai DL; Sussman JL
    Biochemistry; 2002 Sep; 41(35):10810-8. PubMed ID: 12196020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
    Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
    Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
    Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
    Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
    Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.